Alfuzosin Hydrochloride

CAS: 81403-68-1

Ref. TR-A532000

Produktinformation

• Name: Alfuzosin Hydrochloride
• Synonyme: (2RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide hydrochloride, SL 77-499-10, SL 77499-10, Urion, Uroxatral, Xatral, Alfoten, 2-Furancarboxamide, 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, hydrochloride, 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, hydrochloride (1:1), 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, monohydrochloride, Alfuzosin Hcl, Alfuzosina [Spanish], Alfuzosine [French], Alfuzosinehydrochloride, Alfuzosinum [Latin], Furancarboxamide Hydrochloride, Hsdb 7290, KBio3_001866, KBioGR_001616, Mittoval, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahy, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methyl, N-[3-[(4-Amino-6,7-Dimethoxy-2-Quinazolynyl)Methylamino]Propyl]Tetrahydro-2-Furancarboxamide, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide, SL-77,499-10, Mittoval, Urion, Xatral, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxol, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide hydrochloride (1:1), Prestwick0_000322, Prestwick1_000322, SPBio_000429, SPBio_002244, Sl 77-499-10, Sl 77499, Sl-77,499-10, Spectrum2_000505, Spectrum3_001063, Spectrum4_001208, Uroxantral, Uroxatral hydrochloride, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-, amino)propyl)tetrahydro-, ane-2-carboxamide, dro-2-furancarboxamide
• CAS: 81403-68-1

Beschreibung

Applications α1-Adrenoceptor antagonist structurally similar to Prozosin. Antihypertensive. Used in treatment of benign prostatic hypertrophy.
References Ramage, A.G., et al.: Eur. J. Pharmacol., 129, 307 (1986), Deering, A.H.,: Brit. J. Clin. Pharmacol., 25, 417 (1988), Priolo, L.D., et al.: Eur. J. Clin. Pharmacol., 35, 25 (1988),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 425.91
• Formel: C₁₉H₂₈ClN₅O₄
• Farbe/Form: Neat
• InChl: 1H, InChI=1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19, /h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
• InChI Key: InChIKey=YTNKWDJILNVLGX-UHFFFAOYSA-N
• SMILES: COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl